The authors concluded that an increased percentage of FoxP3+ Tregs in PTC tissues compared to FoxP3+ Tregs may be associated with tumor aggressiveness, suggesting that patients with HT concomitant with PTC may have better prognoses than those with simple PTC. Here, FOXP3 is linked to neoplasm.